SUNSHINE BIOPHARMA INC.

Serial Number 97444768
Registration 7963385
700

Registration Progress

Application Filed
Jun 6, 2022
Under Examination
Approved for Publication
Aug 12, 2025
Published for Opposition
Aug 12, 2025
Registered
Sep 30, 2025

Trademark Image

SUNSHINE BIOPHARMA INC.

Basic Information

Serial Number
97444768
Registration Number
7963385
Filing Date
June 6, 2022
Registration Date
September 30, 2025
Published for Opposition
August 12, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 30, 2025
Registration
Registered
Classes
005 035 042

Rights Holder

Sunshine Biopharma Inc.

99
Address
6500 Trans-Canada Highway, 4th Floor
Pointe-Claire, QC H9R0A5
CA

Ownership History

Sunshine Biopharma Inc.

Original Applicant
99
Pointe-Claire, QC CA

Sunshine Biopharma Inc.

Owner at Publication
99
Pointe-Claire, QC CA

Sunshine Biopharma Inc.

Original Registrant
99
Pointe-Claire, QC CA

Legal Representation

Attorney
W. Drew Kastner

USPTO Deadlines

Next Deadline
2094 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250930)
Due Date
September 30, 2031
Grace Period Ends
March 30, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

46 events
Date Code Type Description Documents
Sep 30, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 30, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 18, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 18, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 18, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 12, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 12, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 6, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 2, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 30, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 30, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 30, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Apr 1, 2025 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Apr 1, 2025 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Apr 1, 2025 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Mar 27, 2025 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Sep 3, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Sep 3, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Sep 3, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 27, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 27, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 27, 2024 ALIE A ASSIGNED TO LIE Loading...
Mar 20, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jan 10, 2024 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jan 10, 2024 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jan 10, 2024 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jan 5, 2024 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Oct 5, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 5, 2023 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Oct 5, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 5, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 5, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 5, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 15, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 15, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
May 15, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 11, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 10, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 10, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 21, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 21, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 21, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 21, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 16, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 9, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Dietary supplements consisting of amino acids, minerals and trace elements; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceuticals for the treatment or prevention of coronavirus diseases, respiratory diseases and covid-19
First Use Anywhere: 20190200
First Use in Commerce: 20190200
Class 035
New product commercialization services in the field of nutritional supplements
First Use Anywhere: 20211100
First Use in Commerce: 20211100
Class 042
Pharmaceutical drug development services; pharmaceutical research and development services; development of nutritional supplements; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the field of coronavirus diseases, respiratory diseases and covid-19
First Use Anywhere: 20190600
First Use in Commerce: 20190600

Additional Information

Design Mark
The mark consists of the terms "SUNSHINE BIOPHARMA INC." in blue lettering to the right of an image of a stylized representation of a partial double helix comprised of a left helix of a darker blue and a right helix of a lighter blue. Between the two helixes, are yellow stripes from varying widths commencing with a thin line at the bottom and ending with a thicker band at the top, against a white background.
Color Claim
The color(s) light blue, dark blue, yellow and white is/are claimed as a feature of the mark.

Classification

International Classes
005 035 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMA INC."